B.C. Agatep | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where B.C. Agatep is active.

Explore More

Publication

Featured researches published by B.C. Agatep.

Journal of the American College of Cardiology | 2012

PATIENT KNOWLEDGE OF PHARMACOGENETIC INFORMATION IMPROVES ADHERENCE TO STATIN THERAPY: RESULTS OF THE ADDITIONAL KIF6 RISK OFFERS BETTER ADHERENCE TO STATINS (AKROBATS) TRIAL

S.L. Charland; B.C. Agatep; Robert S. Epstein; Felix W. Frueh; V. Herrera; James Devlin; H. Superko; Eric J. Stanek

Numerous strategies to improve statin adherence have been evaluated; however, none have utilized direct patient communication of genetic information as a motivator. This trial is the first to evaluate this novel technique. AKROBATS ([NCT01068834][1]) was a prospective, nonrandomized intervention

Circulation-cardiovascular Quality and Outcomes | 2012

Abstract 290: Statin Adherence in Males and Females, and the Impact of Knowledge of a Genetic Test: Results from the AKROBATS Trial

S.L. Charland; B.C. Agatep; Bruce J Schrader; Felix W. Frueh; V. Herrera; Miriam Ryvkin; Junaid Shabbeer; James J. Devlin; Robert Superko; Eric J. Stanek

Value in Health | 2012

PDB105 Payor and Prescriber Feasibility Assessment of a Pharmacy Benefit Management (PBM) Diabetes Program Utilizing Pharmacist-Advised Self-Adjusted Basal Insulin

G. Hamid; B.J. Schrader; B.C. Agatep; J.J. Vazhappilly; V. Herrera; M.R. Dalal; Eric J. Stanek; R. Berria; M. Pendergrass; S.L. Charland

Value in Health | 2012

PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population

B.J. Schrader; S.L. Charland; Daniel C. Malone; B.C. Agatep; V. Herrera; G.S. Hawk; Eric J. Stanek

Value in Health | 2012

PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

Daniel C. Malone; S.L. Charland; B.C. Agatep; V. Herrera; G.S. Hawk; B.J. Schrader; Eric J. Stanek

Circulation | 2012

Abstract 16370: Real-World Risk of Thromboembolism or Bleeding with Warfarin or Dabigatran Therapy in Patients with Atrial Fibrillation

Scott L. Charland; Daniel C. Malone; B.C. Agatep; Vivian Herrera; Gosia S Hawk; Bruce J Schrader; Eric J. Stanek

Value in Health | 2011

PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy

B.C. Agatep; S.L. Charland; V. Herrera; G.S. Hawk; Eric J. Stanek

Value in Health | 2011

PSY30 A REAL-WORLD EVALUATION OF ADHERENCE AND PERSISTENCE OF WEIGHT-LOSS PHARMACOTHERAPY IN THE UNITED STATES: 2007-2010

S.L. Charland; B.C. Agatep; Ronald E. Aubert; J. Lazzaro; Eric J. Stanek

Journal of the American College of Cardiology | 2011

A NATIONWIDE SURVEY OF ADOPTION AND PERCEPTION OF PHARMACOGENOMIC TESTING BY U.S. CARDIOLOGISTS

Eric J. Stanek; Christopher L. Sanders; B.C. Agatep; Katherine A. Johansen; Ronald E. Aubert; Mona Khalid; Aanal Patel; Felix W. Frueh; Robert S. Epstein

Journal of Clinical Lipidology | 2011